Introduction

Molecular pathology is revolutionising clinical practice in oncology and pathology, paving the way for precision medicine, and has become a rapidly growing area of research. Skilled molecular pathologists are a critical factor in advancing cancer research and improving patient care.

This conference is an excellent opportunity for attendees to gain a comprehensive understanding of the scope, methods, future directions, and challenges in molecular pathology, with a particular focus on comprehensive genomic profiling in cancer research and clinical settings.

We will discuss innovative approaches for empowering the next generation of molecular pathologists from practical and educational viewpoints. Upcoming applications of multiparametric immunoanalysis, liquid biopsy and artificial intelligence in pathology will be addressed. The meeting will help participants to establish a network of interactions and to build bridges to foster cross disciplinary studies. We are preparing for the future and for the unknown discoveries still to come.

Topics to be covered:

• Next generation molecular pathology
• Comprehensive cancer profiling in clinical diagnostics
• Perspectives of artificial intelligence (AI) in pathology
• Novel approaches for developing and implementing biomarkers in oncology and pathology
• Tumor heterogeneity - Spatial and longitudinal markers

Target audience

This conference will be of interest to a diverse audience including pathologists, molecular pathologists and pathology residents, researchers in the field of molecular diagnostics and precision oncologists. The conference population will thus simulate the multidisciplinary teams that act in the real world to facilitate interdisciplinary research and the multidisciplinary teams caring for patients with cancer.

Scientific Programme Committee

• Ragnhild Lothe, Oslo University Hospital, Norway

• Eli Pikarsky, The Hebrew University of Jerusalem, Israel

• Giorgio Stanta, OECI, Italy

• Luigi M Terracciano, University Hospital Basel, Switzerland

• Sabine Merkelbach-Bruse, University Hospital Cologne, Germany

Follow us on twitter for updates @EACRnews and engage with the conference with #eacrMolecularPathology

Above: the beautiful city of Bergamo
Below: the conference venue